ZTS Zoetis Inc.
Healthcare$80.23-1.34%ClosedMarket Cap: $33.63B
As of 2026-05-26
Valuation
P/E (TTM)
19.74
PEG
2.62
P/B
10.62
P/S
3.59
EV/EBITDA
10.24
DCF Value
$164.03
FCF Yield
6.3%
Div Yield
2.5%
Margins & Returns
Gross Margin
70.8%
Operating Margin
37.6%
Net Margin
27.8%
ROE
62.4%
ROA
17.4%
ROIC
21.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $2.26B | 71.7% | $822.0M | $601.0M | $— | $0.53 |
| Q4 null | $2.39B | 68.9% | $826.0M | $603.0M | $— | $0.50 |
| FY null | $9.47B | 70.5% | $3.60B | $2.67B | $— | $2.00 |
| Q3 null | $2.40B | 70.2% | $936.0M | $721.0M | $— | $0.50 |
| Q2 null | $2.46B | 72.3% | $989.0M | $718.0M | $— | $0.50 |
| Q1 null | $2.22B | 70.5% | $846.0M | $631.0M | $— | $0.50 |
| Q4 null | $2.32B | 68.0% | $765.0M | $581.0M | $— | $0.43 |
| FY null | $9.26B | 69.1% | $3.39B | $2.49B | $— | $1.73 |
| Q3 null | $2.39B | 69.2% | $920.0M | $682.0M | $— | $0.43 |
| Q2 null | $2.36B | 70.2% | $906.0M | $624.0M | $— | $0.43 |
| Q1 null | $2.19B | 68.9% | $801.0M | $599.0M | $— | $0.43 |
| Q4 2023 | $2.21B | 65.4% | $709.0M | $525.0M | $1.14 | $0.38 |